Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD

Phase 3 Unknown 240 enrolled Henan University of Traditional Chinese Medicine Jiangsu Famous Medical Technology Co., Ltd. · collab

RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study is to evaluate the effectiveness of Yong Chong Cao capsule on outcomes in patients with mild to severe Chronic Obstructive Pulmonary Disease (COPD).

Timeline

Start: 2018-06-20
Primary completion: 2019-12
Completion: 2020-06

Outcome

Met primary endpoint

paper Compared with BLC, YChCC significantly reduced the number of acute exacerbations (FAS: p = 0.002; PPS: p = 0.003) PMID 41295088 ↗

Publications

Li S, Xie Y, Lin L, Wu L, Yu X, Ma Z, Yin Q. The Effectiveness of Yong Chong Cao Capsule in Patients With Mild to Severe COPD: A Multi-Center, Randomized, Active-Controlled Trial. J Evid Based Med. 2025 Dec;18(4):e70091. doi: 10.1111/jebm.70091. Epub 2025 Nov 26.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bailing	Traditional medicine (herbal / TCM)	1 g	—
Subject	Yong Chong Cao	Traditional medicine (herbal / TCM)	1 g	—
Background	Salbutamol	Unknown	100 ug	Inhaled
Background	Salmeterol / fluticasone	Unknown	—	Inhaled
Background	Tiotropium	Other / unclassified	18 ug	Inhaled